Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Short-term Investments (2018 - 2025)

Lexaria Bioscience's Short-term Investments history spans 8 years, with the latest figure at $143267.0 for Q3 2025.

  • Quarterly results put Short-term Investments at $143267.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Aug 2025 was $143267.0 (changed N/A YoY), and the annual figure for FY2025 was $143267.0, changed.
  • Short-term Investments for Q3 2025 was $143267.0 at Lexaria Bioscience, up from $33540.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $833841.0 in Q3 2021 to a low of $33540.0 in Q2 2025.
  • The 5-year median for Short-term Investments is $268632.0 (2023), against an average of $267553.8.
  • The sharpest move saw Short-term Investments skyrocketed 4215.72% in 2021, then tumbled 82.82% in 2024.
  • Year by year, Short-term Investments stood at $493424.0 in 2021, then tumbled by 45.34% to $269707.0 in 2022, then tumbled by 73.15% to $72427.0 in 2023, then tumbled by 44.94% to $39875.0 in 2024, then surged by 259.29% to $143267.0 in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $143267.0, $33540.0, and $73915.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.